Año 2023 / Volumen 115 / Número 1
Original
Endoscopic submucosal dissection versus surgery for patients with undifferentiated early gastric cancer

3-9

DOI: 10.17235/reed.2022.8564/2021

Harold Benites-Goñi, Fernando Palacios-Salas, Andrea Carlin-Ronquillo, Carlos Díaz-Arocutipa, Alejandro Piscoya, Adrián Hernández,

Resumen
Background and aims: endoscopic submucosal dissection (ESD) is the standard treatment for differentiated early gastric cancer (EGC). However, its expanded indication for undifferentiated EGC is controversial. In this study, the efficacy and safety of ESD versus surgery in patients with undifferentiated EGC were compared. Methods: four databases were searched until February 24, 2022, for studies assessing patients with undifferentiated EGC that met an expanded indication for endoscopic resection and who were treated with ESD or surgery. Primary outcomes were all-cause mortality and any recurrence. Secondary outcomes were complete histological resection, local recurrence, metachronous recurrence, synchronous recurrence, distant metastasis, overall complication, and bleeding. All meta-analyses were performed using a random-effects models. Unadjusted (risk ratio [RR]) and adjusted (aRR and hazard ratio [aHR]) estimates with 95 % confidence interval (CI) were calculated. Results: seven cohort studies were included (n = 2637). The use of ESD was significantly associated with higher all-cause mortality compared to surgery (RR, 2.17; 95 % CI, 1.24-3.81); adjusted all-cause mortality effects were not significant (aRR, 2.28; 95 % CI, 0.95-5.47 and aHR, 1.97; 95 % CI, 0.85-4.53). ESD was associated with a higher risk of any recurrence using unadjusted (RR, 5.24; 95 % CI, 1.49-18.46) and adjusted (aRR, 7.89; 95 % CI, 1.52-40.95 and aHR, 3.73; 95 % CI, 1.17-11.90) estimates. The risk of local recurrence, synchronous recurrence and bleeding were significantly higher for ESD versus surgery. No significant differences were found for other secondary outcomes. Conclusions: although ESD is associated with a higher risk of any recurrence, adjusted all-cause mortality is similar during follow-up. Overall complications were similar between ESD and surgery.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
2. Reim D, Loos M, Vogl F, et al. Prognostic Implications of the Seventh Edition of the International Union Against Cancer Classification for Patients With Gastric Cancer: The Western Experience of Patients Treated in a Single-Center European Institution. J Clin Oncol. 2013;31(2):263-271.
3. Murakami T. Early cancer of the stomach. World J Surg. 1979;3(6):685-691.
4. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1-21.
5. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3(4):219-225.
6. Kim J-H. Important considerations when contemplating endoscopic resection of undifferentiated-type early gastric cancer. World J Gastroenterol. 2016;22(3):1172.
7. Gastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG), Hasuike N, Ono H, et al. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607). Gastric Cancer. 2018;21(1):114-123.
8. Abe S, Oda I, Suzuki H, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45(09):703-707.
9. Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535-b2535.
10. Chung MW, Jeong O, Park YK, et al. Comparison on the Long Term Outcome between Endoscopic Submucosal Dissection and Surgical Treatment for Undifferentiated Early Gastric Cancer. Korean J Gastroenterol. 2014;63(2):90.
11. Lee S, Choi KD, Han M, et al. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer. 2018;21(3):490-499.
12. Park JC, Lee YK, Kim SY, et al. Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis. Surg Endosc. 2018;32(4):2046-2057.
13. Hahn KY, Park CH, Lee YK, et al. Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. Surg Endosc. 2018;32(1):73-86.
14. Lim JH, Kim J, Kim SG, Chung H. Long-term clinical outcomes of endoscopic vs. surgical resection for early gastric cancer with undifferentiated histology. Surg Endosc. 2019;33(11):3589-3599.
15. Guo A, Du C, Tian S, et al. Long-term outcomes of endoscopic submucosal dissection versus surgery for treating early gastric cancer of undifferentiated-type. Medicine (Baltimore). 2020;99(22):e20501.
16. Ahn JY, Kim Y-I, Shin WG, et al. Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study. Gastric Cancer. 2021;24(3):731-743.
17. Hu J, Zhao Y, Ren M, et al. The Comparison between Endoscopic Submucosal Dissection and Surgery in Gastric Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2018;2018:1-10.
18. Abdelfatah MM, Barakat M, Ahmad D, et al. Long‐term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(4):418-424.
19. Li H, Feng L-Q, Bian Y-Y, et al. Comparison of endoscopic submucosal dissection with surgical gastrectomy for early gastric cancer: An updated meta-analysis. World J Gastrointest Oncol. 2019;11(2):161-171.
20. Liu Q, Ding L, Qiu X, Meng F. Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer: A systematic review and meta-analysis. Int J Surg. 2020;73:28-41.
21. Hirasawa T, Gotoda T, Miyata S, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12(3):148-152.
22. Abdelfatah MM, Barakat M, Lee H, et al. The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis. Gastrointest Endosc. 2018;87(2):338-347.
23. Bang CS, Baik GH, Shin IS, et al. Endoscopic submucosal dissection for early gastric cancer with undifferentiated-type histology: A meta-analysis. World J Gastroenterol. 2015;21(19):6032-6043.
24. Ninomiya, Yanagisawa, Kato, Tomimatsu. Unrecognizable Intramucosal Spread of Diffuse-Type Mucosal Gastric Carcinomas of Less than 20 mm in Size. Endoscopy. 2000;32(8):604-608.
25. Lee BE, Kim GH, Park DY, et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol. 2010;10(1):97.
26. Lee A, Chung H. Endoscopic Resection of Undifferentiated-type Early Gastric Cancer. J Gastric Cancer. 2020;20(4):345.
27. Huh C-W, Ma DW, Kim B-W, Kim JS, Lee SJ. Endoscopic Submucosal Dissection versus Surgery for Undifferentiated-Type Early Gastric Cancer: A Systematic Review and Meta-Analysis. Clin Endosc. 2021;54(2):202-210.
28. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of Metachronous Multiple Early Gastric Cancers after Endoscopic Mucosal Resection. Endoscopy. 2005;37(10):990-993.
29. Kato M, Nishida T, Yamamoto K, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 2013;62(10):1425-1432.
30. Lee JH, Kim JG, Jung H-K, et al. Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach. J Gastric Cancer. 2014;14(2):87.
31. Kwon K-J, Shim K-N, Song E-M, et al. Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer. 2014;17(1):43-53.
Artículos relacionados

Imagen en Patología Digestiva

Sustained silence of a small signet ring cell carcinoma

DOI: 10.17235/reed.2023.9891/2023

Carta

Pseudo-submucosal tumor in the colon: seeing is believing

DOI: 10.17235/reed.2023.9773/2023

Carta

Successful endoscopic removal of a giant duodenal bulb mass

DOI: 10.17235/reed.2022.8595/2022

Carta

Primary squamous cell carcinoma of the stomach: a rare entity

DOI: 10.17235/reed.2018.5900/2018

Imagen en Patología Digestiva

A rare mass in the duodenal bulb: Brunner’s glands cystadenoma

DOI: 10.17235/reed.2018.5344/2017

Carta al Editor

Gastric neuroendocrine tumor presenting with gastrointestinal bleeding

DOI: 10.17235/reed.2015.3998/2015

Carta al Editor

Endoscopic submucosal dissection for a gastric fibrolipoma

DOI: 10.17235/reed.2015.3982/2015

Instrucciones para citar
Benites-Goñi H, Palacios-Salas F, Carlin-Ronquillo A, Díaz-Arocutipa C, Piscoya A, Hernández A, et all. Endoscopic submucosal dissection versus surgery for patients with undifferentiated early gastric cancer. 8564/2021


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 1666 veces.
Este artículo ha sido descargado 232 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 31/12/2021

Aceptado: 14/03/2022

Prepublicado: 17/03/2022

Publicado: 12/01/2023

Tiempo de revisión del artículo: 63 días

Tiempo de prepublicación: 76 días

Tiempo de edición del artículo: 377 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas